Patients must be part of a specialist weight management service, which requires a referral from a healthcare professional
Not Ill catch up this weekend sleep
GLP-1 receptor agonists (semaglutide, dulaglutide, liraglutide) are prescribed for type 2 diabetes and weight management in the UK
Autoimmune & Inflammatory Conditions: Some peer-reviewed literature has explored naltrexone at low doses in the context of MS, Crohn's, rheumatoid arthritis, and lupus, with preliminary research examining potential effects on immune activity and limit the immune system's tendency to attack the body's own tissues , Chronic Pain Research Area: Early-stage literature has examined low-dose naltrexone in the context of fibromyalgia, chronic widespread pain, and complex regional pain concerns by calming brain pain-signaling cells (microglia) and promoting the body's endogenous endorphin production 3,4 Weight Management Support: at the 8 mg dose, may support weight goals by influencing appetite regulation and managing food cravings through the brain's reward pathways 5,6 Mood & Mental Health: early research suggests healthy mood related outcomes, particularly in patients where inflammation may be contributing to mental health symptoms Fatigue Concerns: explored as a potential support for ME/CFS and long COVID, with some patients reporting healthy changes in energy levels Gut Health & IBD Support: a meaningful body of research in Crohn's and ulcerative colitis shows healthy changes in gut health and improvements in quality of life, including in pediatric populations Nervous System Balance: preliminary research has examined a possible protective support for brain and nerve tissue, with ongoing clinical interest in factors relating to long-term neurological health Potential Side Effects LDN has a well-established tolerability profile when used as directed
